IL13 and Alzheimer disease: In the case of the psoriasis model, a TH17-associated cytokine cocktail (IL-17A and IL-22) was used, and in the case of the AD model, a TH2-associated cytokine cocktail (IL-4, IL-5 and IL-13) was used.